A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/196 (2006.01) A61K 9/00 (2006.01) A61K 31/403 (2006.01) A61K 31/404 (2006.01) A61K 31/4045 (2006.01) A61K 31/4196 (2006.01) A61K 31/422 (2006.01) A61K 31/454 (2006.01) A61P 25/00 (2006.01) A61P 25/06 (2006.01) A61P 27/00 (2006.01)
Patent
CA 2661819
Therapeutic regimens and dosage forms are disclosed for the treatment of migraine headache. The regimens preferably combine a serotonin receptor agonist, such as sumatriptan, eletriptan or almotriptan, with a fast acting formulation of diclofenac potassium.
La présente invention concerne des régimes et des formes posologiques thérapeutiques destinés au traitement de la migraine. De préférence, les régimes combinent un agoniste des récepteurs de la sérotonine, tel que le sumatriptan, l'élétriptan ou l'almotriptan, avec une formulation à action rapide de diclofénac potassique.
Maichle William R.
Reiner Alberto
Reiner Giorgio
Whatley Carl L.
Apr Applied Pharma Research S.a.
Kowa Pharmaceuticals America Inc.
Ridout & Maybee Llp
LandOfFree
Fixed combination dosage forms for the treatment of migraine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fixed combination dosage forms for the treatment of migraine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fixed combination dosage forms for the treatment of migraine will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2091314